The bill provides a targeted ~$1.18 billion boost to Congressionally Directed Medical Research Programs to preserve and expand specified research priorities, trading increased taxpayer cost and reduced DoD budget flexibility plus administrative complications for sustained, congressionally directed research support.
Researchers, hospitals, and medical research programs receive an additional ~$1.18 billion for the Congressionally Directed Medical Research Programs, preserving and expanding research activities and grants.
Ongoing projects and allocated initiatives are protected because the bill requires the Secretary of Defense to obligate and expend funds to preserve program continuity, reducing disruption to multiyear research efforts.
Congressional priorities and peer‑reviewed initiatives specified in the 2024 explanatory statement are ensured funding, aligning CDMRP spending with lawmakers' targeted research objectives (including veteran‑related research).
Taxpayers absorb the cost of the ~$1.18 billion increase, which could add to the federal deficit or require shifting funds away from other priorities.
Specifying precise allocations and priorities limits the Department of Defense's flexibility to reprogram funds, which may reduce the DoD's ability to respond to emergent national security or health needs.
The retroactive effective date could complicate budget accounting and require administrative adjustments to obligations already made under Public Law 119–4, increasing administrative burden and potential compliance issues.
Based on analysis of 2 sections of legislative text.
Raises the FY2025 total for Congressionally Directed Medical Research Programs to $41,576,684,000 and requires DoD to implement the funds consistent with the FY2024 explanatory statement.
Introduced June 11, 2025 by André Carson · Last progress June 11, 2025
Increases the FY2025 appropriations total for Congressionally Directed Medical Research Programs by $1,181,612,000 (from $40,395,072,000 to $41,576,684,000) and makes that change retroactive to the enactment of the FY2025 continuing appropriations law. Directs the Department of Defense to obligate and expend the added funds consistent with the Consolidated Appropriations Act, 2024 explanatory statement so that all listed research programs, peer-reviewed initiatives, and projects are supported and program continuity and specified allocations and priorities are preserved.